Neoplasms, Colorectal Terminated Phase 1 Trials for Figitumumab (DB11685)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00976508Figitumumab Combined With Pegvisomant For Advanced Solid TumorsTreatment